Cure Alzheimer's Fund: Targeting Breakthrough Research

Boston—A new study published in Molecular Neurodegeneration unexpectedly showed that a retired Russian hay fever drug, Dimebon, which has shown promise in improving and stabilizing cognition in Alzheimer’s disease, has the surprising effect of increasing the levels of beta amyloid peptide, a mol... (Read more)

Washington, December 17, 2009 — President Obama this week signed a bill into law that includes funding to support the Boston-based Cure Alzheimer’s Fund’s efforts to find cure for Alzheimer’s disease. Submitted as part of the Consolidated Appropriations Act of 2010... (Read more)

May Lead To New Treatments for Devastating Disease Chronic sleep deprivation in mice with Alzheimer's disease type changes makes Alzheimer's brain plaques appear earlier and more often, researchers lead by Cure Alzheimer's Fund's Dr. David Holtzman at Washington University School of Medicine in St... (Read more)